Immunovant, Inc.

IMVT - Company ID 0001764013

Market cap$8.16 B

Rank#1075

Filings611

Immunovant, Inc. has filed 611 public company documents between 2019 and 2026. The most frequent type is insider trade (300 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchIMVT overview$8.16 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #1075See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with AMGNPeer viewPut IMVT beside AMGN across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow IMVT via RSS

Similar companies to research next

AMGNAmgen Inc.

GILDGilead Sciences, Inc.AARGXargenx SE RRVMDRevolution Medicines, Inc.

BIIBBiogen Inc.

MRNAModerna, Inc.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
UPLOAD	SEC correspondence	5y ago2021-02-02	-	View filing
4	Insider trade	5y ago2021-01-25	2021-01-22	View filing
424B7	424B7	5y ago2021-01-15	-	View filing
424B5	Prospectus supplement	5y ago2021-01-15	-	View filing
EFFECT	EFFECT	5y ago2021-01-14	-	View filing
3	New insider ownership	5y ago2021-01-14	2021-01-11	View filing
CORRESP	Company correspondence	5y ago2021-01-12	-	View filing
UPLOAD	SEC correspondence	5y ago2021-01-11	-	View filing
S-3	Securities registration	5y ago2021-01-04	-	View filing

Immunovant, Inc.

Similar companies to research next

Year